Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy
Clinical trial NCT04758533 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04758533
- Sponsor
- Hospital Infantil Universitario Niño Jesús, Madrid, Spain
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-19
- Primary completion
- 2026-04-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.